ReviewTranslational neurodegeneration2024

Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease.

Lewis K Penny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.